Your browser doesn't support javascript.
loading
A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo.
Giannakopoulou, Eirini; Lehander, Madeleine; Virding Culleton, Stina; Yang, Weiwen; Li, Yingqian; Karpanen, Terhi; Yoshizato, Tetsuichi; Rustad, Even H; Nielsen, Morten Milek; Bollineni, Ravi Chand; Tran, Trung T; Delic-Sarac, Marina; Gjerdingen, Thea Johanne; Douvlataniotis, Karolos; Laos, Maarja; Ali, Muhammad; Hillen, Amy; Mazzi, Stefania; Chin, Desmond Wai Loon; Mehta, Adi; Holm, Jeppe Sejerø; Bentzen, Amalie Kai; Bill, Marie; Griffioen, Marieke; Gedde-Dahl, Tobias; Lehmann, Sören; Jacobsen, Sten Eirik W; Woll, Petter S; Olweus, Johanna.
Afiliação
  • Giannakopoulou E; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Lehander M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Virding Culleton S; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Yang W; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Li Y; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Karpanen T; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Yoshizato T; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Rustad EH; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Nielsen MM; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Bollineni RC; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Tran TT; Genomics Group, Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
  • Delic-Sarac M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Gjerdingen TJ; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Douvlataniotis K; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Laos M; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Ali M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Hillen A; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Mazzi S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Chin DWL; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Mehta A; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Holm JS; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Bentzen AK; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Bill M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Griffioen M; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Gedde-Dahl T; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Lehmann S; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Jacobsen SEW; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Woll PS; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Olweus J; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Nat Cancer ; 4(10): 1474-1490, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37783807
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega